A Novel Multi-Target Small Molecule, LCC-09, Inhibits Stemness and Therapy-Resistant Phenotypes of Glioblastoma Cells by Increasing miR-34a and Deregulating the DRD4/Akt/mTOR Signaling Axis

The management of glioblastomas (GBMs) is challenged by the development of therapeutic resistance and early disease recurrence, despite multi-modal therapy. This may be attributed to the presence of glioma stem cells (GSCs) which are known to survive radio- and chemotherapy, by circumventing death s...

Descripción completa

Detalles Bibliográficos
Autores principales: Wen, Ya-Ting, Wu, Alexander TH, Bamodu, Oluwaseun Adebayo, Wei, Li, Lin, Chien-Min, Yen, Yun, Chao, Tsu-Yi, Mukhopadhyay, Debabrata, Hsiao, Michael, Huang, Hsu-Shan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6826618/
https://www.ncbi.nlm.nih.gov/pubmed/31561595
http://dx.doi.org/10.3390/cancers11101442

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6826618/
https://www.ncbi.nlm.nih.gov/pubmed/31561595
http://dx.doi.org/10.3390/cancers11101442

Ejemplares similares